Serum Institute of India seeks indemnity!


New Delhi: Serum Institute of India (SII), the company producing the AstraZeneca Covishield doses, has sought legal protection from any claims linked to the use of their Covid-19 vaccines, reports suggested.

India has so far not given any manufacturer of a Covid-19 vaccine indemnity against the costs of compensation for any severe side effects.

The Indian government could likely be in favour of granting indemnity to foreign vaccine makers such as Moderna and Pfizer. According to the latest update, Indian vaccine maker Serum Institute of India (SII) has sought Indemnity, sources have claimed.

Comments are closed.